These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11031258)

  • 21. Co-clustering of Fcgamma and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein.
    Koncz G; Tóth GK; Bökönyi G; Kéri G; Pecht I; Medgyesi D; Gergely J; Sármay G
    Eur J Biochem; 2001 Jul; 268(14):3898-906. PubMed ID: 11453982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The SH2-domain of SHIP1 interacts with the SHIP1 C-terminus: impact on SHIP1/Ig-α interaction.
    Mukherjee O; Weingarten L; Padberg I; Pracht C; Sinha R; Hochdörfer T; Kuppig S; Backofen R; Reth M; Huber M
    Biochim Biophys Acta; 2012 Feb; 1823(2):206-14. PubMed ID: 22182704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantification of change in phosphorylation of BCR-ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cells.
    Liang X; Hajivandi M; Veach D; Wisniewski D; Clarkson B; Resh MD; Pope RM
    Proteomics; 2006 Aug; 6(16):4554-64. PubMed ID: 16858728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The SH2-containing adapter protein GRB10 interacts with BCR-ABL.
    Bai RY; Jahn T; Schrem S; Munzert G; Weidner KM; Wang JY; Duyster J
    Oncogene; 1998 Aug; 17(8):941-8. PubMed ID: 9747873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine phosphorylation of shc in response to B cell antigen receptor engagement depends on the SHIP inositol phosphatase.
    Ingham RJ; Okada H; Dang-Lawson M; Dinglasan J; van Der Geer P; Kurosaki T; Gold MR
    J Immunol; 1999 Dec; 163(11):5891-5. PubMed ID: 10570274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells.
    Sattler M; Salgia R
    Leukemia; 1998 May; 12(5):637-44. PubMed ID: 9593259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tyrosine phosphorylation of murine Crkl.
    de Jong R; Haataja L; Voncken JW; Heisterkamp N; Groffen J
    Oncogene; 1995 Oct; 11(8):1469-74. PubMed ID: 7478571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.
    Andoniou CE; Thien CB; Langdon WY
    Oncogene; 1996 May; 12(9):1981-9. PubMed ID: 8649859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL).
    Sattler M; Salgia R; Shrikhande G; Verma S; Pisick E; Prasad KV; Griffin JD
    J Biol Chem; 1997 Apr; 272(15):10248-53. PubMed ID: 9092574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A BCR-ABL mutant lacking direct binding sites for the GRB2, CBL and CRKL adapter proteins fails to induce leukemia in mice.
    Johnson KJ; Griswold IJ; O'Hare T; Corbin AS; Loriaux M; Deininger MW; Druker BJ
    PLoS One; 2009 Oct; 4(10):e7439. PubMed ID: 19823681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.
    Peng Q; Malhotra S; Torchia JA; Kerr WG; Coggeshall KM; Humphrey MB
    Sci Signal; 2010 May; 3(122):ra38. PubMed ID: 20484116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The tetramerization domain-independent Ras activation by BCR-ABL oncoprotein in hematopoietic cells.
    Tauchi T; Okabe S; Miyazawa K; Ohyashiki K
    Int J Oncol; 1998 Jun; 12(6):1269-76. PubMed ID: 9592185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the Src homology 2 (SH2) domain and C-terminus tyrosine phosphorylation sites of SH2-containing inositol phosphatase (SHIP) in the regulation of insulin-induced mitogenesis.
    Wada T; Sasaoka T; Ishiki M; Hori H; Haruta T; Ishihara H; Kobayashi M
    Endocrinology; 1999 Oct; 140(10):4585-94. PubMed ID: 10499514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosine phosphorylation of SHIP promotes its proteasomal degradation.
    Ruschmann J; Ho V; Antignano F; Kuroda E; Lam V; Ibaraki M; Snyder K; Kim C; Flavell RA; Kawakami T; Sly L; Turhan AG; Krystal G
    Exp Hematol; 2010 May; 38(5):392-402, 402.e1. PubMed ID: 20304029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural requirements for function of the Crkl adapter protein in fibroblasts and hematopoietic cells.
    Senechal K; Heaney C; Druker B; Sawyers CL
    Mol Cell Biol; 1998 Sep; 18(9):5082-90. PubMed ID: 9710592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two distinct tyrosine-based motifs enable the inhibitory receptor FcgammaRIIB to cooperatively recruit the inositol phosphatases SHIP1/2 and the adapters Grb2/Grap.
    Isnardi I; Lesourne R; Bruhns P; Fridman WH; Cambier JC; Daëron M
    J Biol Chem; 2004 Dec; 279(50):51931-8. PubMed ID: 15456754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elucidation of protein interactions necessary for the maintenance of the BCR-ABL signaling complex.
    Gregor T; Bosakova MK; Nita A; Abraham SP; Fafilek B; Cernohorsky NH; Rynes J; Foldynova-Trantirkova S; Zackova D; Mayer J; Trantirek L; Krejci P
    Cell Mol Life Sci; 2020 Oct; 77(19):3885-3903. PubMed ID: 31820037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRKL binding to BCR-ABL and BCR-ABL transformation.
    Kolibaba KS; Bhat A; Heaney C; Oda T; Druker BJ
    Leuk Lymphoma; 1999 Mar; 33(1-2):119-26. PubMed ID: 10194128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C3G is tyrosine-phosphorylated after integrin-mediated cell adhesion in normal but not in Bcr/Abl expressing cells.
    de Jong R; van Wijk A; Heisterkamp N; Groffen J
    Oncogene; 1998 Nov; 17(21):2805-10. PubMed ID: 9840945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CrkL functions as a nuclear adaptor and transcriptional activator in Bcr-Abl-expressing cells.
    Rhodes J; York RD; Tara D; Tajinda K; Druker BJ
    Exp Hematol; 2000 Mar; 28(3):305-10. PubMed ID: 10720695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.